CARR EDWARD 4
4 · Dianthus Therapeutics, Inc. /DE/ · Filed Jan 26, 2024
Insider Transaction Report
Form 4
CARR EDWARD
CHIEF ACCOUNTING OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2024-01-24+80,000→ 80,000 totalExercise: $17.88Exp: 2034-01-23→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.